v3.26.1
STOCKHOLDERS' EQUITY
3 Months Ended
Feb. 28, 2026
Equity [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 15—STOCKHOLDERS’ EQUITY:

Share repurchase program
In September 2021, the Company’s board of directors authorized the repurchase of up to $500,000 of the outstanding shares of Concentrix common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. In January 2025, the Company’s board of directors extended the share repurchase program by authorizing an increase of the amount remaining for share repurchases under the existing share repurchase authorization to $600,000. The repurchase program has no termination date and may be suspended or discontinued at any time.
During the three months ended February 28, 2026 and February 28, 2025, under the share repurchase program, the Company repurchased 1,081 and 540 shares, respectively, of its common stock for an aggregate purchase price of $43,194 and $25,846, respectively. The share repurchases were made on the open market and the shares repurchased by the Company are held in treasury for general corporate purposes. At February 28, 2026, approximately $396,602 remained available for share repurchases under the existing authorization from the Company’s board of directors.
Dividends
During fiscal years 2026 and 2025, the Company paid the following dividends per share approved by the Company’s board of directors:

Announcement Date
Record Date
Per Share Dividend Amount
Payment Date
January 15, 2025
January 31, 2025
$0.33275
February 11, 2025
March 26, 2025
April 25, 2025
$0.33275
May 6, 2025
June 26, 2025
July 25, 2025
$0.33275
August 5, 2025
September 25, 2025
October 24, 2025
$0.36
November 4, 2025
January 13, 2026
January 30, 2026
$0.36
February 10, 2026
On March 24, 2026, the Company announced a cash dividend of $0.36 per share to stockholders of record as of April 24, 2026, payable on May 5, 2026.